FDA Partially Grants Petition on Generic Opioid Testing

March 10, 2017
Drugs Quality
The FDA partially granted a petition filed on behalf of Purdue Pharma concerning generic versions of an extended-release opioid.

To View This Article:

Login

Subscribe To FDAnews

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More